$CDLX
Cardlytics, Inc. Stock $cdlx

$cdlx Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000166607124000167 Filed on November 06, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$67.06M
YoY Change		-15.12%
Cost Of Revenue		$30.68M
YoY Change		-15.12%
Gross Profit		$36.38M
YoY Change		-15.11%
Gross Profit Margin		54.26%
Selling, General & Admin		$25.24M
YoY Change		-15.08%
% of Gross Profit		69.37%
Research & Development		$13.19M
YoY Change		6.15%
% of Gross Profit		36.27%
Depreciation & Amortization		$6.970M
YoY Change		16.36%
% of Gross Profit		19.16%
Operating Expenses		$38.43M
YoY Change		-8.82%
Operating Profit		-$148.5M
YoY Change		619.28%
Interest Expense		$3.364M
YoY Change		-201.63%
% of Operating Profit
Other Income/Expense, Net		$3.364M
YoY Change		-201.51%
Pretax Income		-$145.2M
YoY Change		505.78%
Income Tax
% Of Pretax Income
Net Earnings		-$145.2M
YoY Change		505.78%
Net Earnings / Revenue		-216.51%
Basic Earnings Per Share		-$2.90
Diluted Earnings Per Share		-$2.90
COMMON SHARES
Basic Shares Outstanding	50.82M shares	49.84M shares
Diluted Shares Outstanding		50.03M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$66.99M
YoY Change		-25.65%
Cash & Equivalents		$66.99M
Short-Term Investments
Other Short-Term Assets		$6.787M
YoY Change		-8.28%
Inventory
Prepaid Expenses
Receivables		$105.6M
Other Receivables		$3.968M
Total Short-Term Assets		$183.3M
YoY Change		-10.83%
LONG-TERM ASSETS
Property, Plant & Equipment		$2.847M
YoY Change		-5.26%
Goodwill		$159.4M
YoY Change		-54.8%
Intangibles		$12.83M
YoY Change		-70.25%
Long-Term Investments
YoY Change
Other Assets		$2.169M
YoY Change		11.75%
Total Long-Term Assets		$216.1M
YoY Change		-49.67%
TOTAL ASSETS
Total Short-Term Assets		$183.3M
Total Long-Term Assets		$216.1M
Total Assets		$399.4M
YoY Change		-37.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$3.927M
YoY Change		12.88%
Accrued Expenses		$8.359M
YoY Change		-13.52%
Deferred Revenue		$2.064M
YoY Change		-37.89%
Short-Term Debt		$45.79M
YoY Change		52.63%
Long-Term Debt Due		$7.000K
YoY Change
Total Short-Term Liabilities		$155.9M
YoY Change		-13.13%
LONG-TERM LIABILITIES
Long-Term Debt		$167.4M
YoY Change		-26.27%
Other Long-Term Liabilities		$17.00K
YoY Change		-99.43%
Total Long-Term Liabilities		$17.00K
YoY Change		-99.99%
TOTAL LIABILITIES
Total Short-Term Liabilities		$155.9M
Total Long-Term Liabilities		$17.00K
Total Liabilities		$329.7M
YoY Change		-19.5%
SHAREHOLDERS EQUITY
Retained Earnings		-$1.285B
YoY Change		27.17%
Common Stock		$1.356B
YoY Change		10.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$69.70M
YoY Change
Total Liabilities & Shareholders Equity		$399.4M
YoY Change		-37.1%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$145.2M
YoY Change		505.78%
Depreciation, Depletion And Amortization		$6.970M
YoY Change		16.36%
Cash From Operating Activities		$1.385M
YoY Change		16.39%
INVESTING ACTIVITIES
Capital Expenditures		$5.257M
YoY Change		66.89%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities		-$5.257M
YoY Change		66.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-388.0K
YoY Change		-1393.33%
NET CHANGE
Cash From Operating Activities		1.385M
Cash From Investing Activities		-5.257M
Cash From Financing Activities		-388.0K
Net Change In Cash		-4.260M
YoY Change		120.73%
FREE CASH FLOW
Cash From Operating Activities		$1.385M
Capital Expenditures		$5.257M
Free Cash Flow		-$3.872M
YoY Change		97.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Entity File Number EntityFileNumber	001-38386
CY2023Q3	cdlx	Adjusted Contribution AdjustedContribution	42861000	usd
	cdlx	Adjusted Contribution AdjustedContribution	109825000	usd
	cdlx	Adjusted Contribution AdjustedContribution	111339000	usd
CY2024Q3	cdlx	Adjusted Contribution AdjustedContribution	36382000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001666071
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30308
	dei	City Area Code CityAreaCode	(888)
	dei	Local Phone Number LocalPhoneNumber	798-5802
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	CDLX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50822443	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66988000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	91830000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8065000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10249000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31694000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29956000	usd
CY2024Q3	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1200000	usd
CY2023Q3	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	600000	usd
CY2023Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	43560000	usd
CY2022Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	104121000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2467000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1111272000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	134798000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	574144000	usd
	us-gaap	Revenues Revenues	220037000	usd
CY2023Q3	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	36144000	usd
	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	94476000	usd
CY2024Q3	cdlx	Delivery Costs DeliveryCosts	7830000	usd
CY2023Q3	cdlx	Delivery Costs DeliveryCosts	7012000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-145182000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	58000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66988000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90140000	usd
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	105587000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	120622000	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3968000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5379000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6097000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3323000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6933000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7310000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12826000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	35003000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	159429000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	277202000	usd
CY2024Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	31859000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	24643000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2169000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2735000	usd
CY2024Q3	us-gaap	Assets Assets	399393000	usd
CY2023Q4	us-gaap	Assets Assets	574144000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8250000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6787000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3927000	usd
CY2024Q3	us-gaap	Revenues Revenues	67057000	usd
CY2024Q3	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	30675000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14161000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13194000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12430000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12076000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15561000	usd
CY2024Q3	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	0	usd
CY2023Q3	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	8281000	usd
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	CARDLYTICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3039436
	dei	Entity Address Address Line1 EntityAddressAddressLine1	675 Ponce de Leon Ave. NE, Suite 4100
CY2024Q3	us-gaap	Assets Current AssetsCurrent	183330000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	223928000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2847000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4425000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11662000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8359000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9587000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	45789000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
CY2024Q3	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	30783000	usd
CY2023Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	48867000	usd
CY2024Q3	cdlx	Customer Incentive Liability CustomerIncentiveLiability	49912000	usd
CY2023Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	52678000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2064000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2405000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2361000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2127000	usd
CY2024Q3	cdlx	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	4463000	usd
CY2023Q4	cdlx	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	39398000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	155908000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	171149000	usd
CY2024Q3	us-gaap	Senior Notes SeniorNotes	167448000	usd
CY2023Q4	us-gaap	Senior Notes SeniorNotes	227504000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6323000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6391000	usd
CY2024Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	usd
CY2023Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	67000	usd
CY2024Q3	us-gaap	Other Long Term Debt OtherLongTermDebt	0	usd
CY2023Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	30000000	usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4162000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	73000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	329696000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	439346000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50342000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50342000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39728000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39728000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1356173000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1243594000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1498000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1284987000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	69697000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	399393000	usd
CY2023Q3	us-gaap	Revenues Revenues	79005000	usd
	us-gaap	Revenues Revenues	204301000	usd
	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	108698000	usd
	cdlx	Delivery Costs DeliveryCosts	21664000	usd
	cdlx	Delivery Costs DeliveryCosts	20451000	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13163000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	41306000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	43314000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39712000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	38841000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42712000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44907000	usd
CY2023Q3	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	78000	usd
	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	162000	usd
	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-8146000	usd
CY2024Q3	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	100000	usd
	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	110000	usd
	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-15045000	usd
CY2024Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	131595000	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	131595000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6970000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5990000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19749000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19765000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	215603000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	99657000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	391486000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	252785000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-148546000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20652000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-187185000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-32748000	usd
CY2024Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1479000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-915000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3859000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1497000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4843000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2399000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4312000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	379000	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13017000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3364000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3314000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13470000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1118000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-145182000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23966000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-173715000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33866000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-23966000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-173715000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-33866000	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.90
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.90
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.66
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.66
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.95
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.95
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50028000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50028000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37982000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37982000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47469000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47469000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35502000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35502000	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-145182000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-23966000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-173715000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-33866000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4451000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2261000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3965000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-294000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-149633000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21705000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-177680000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-34160000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	134798000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35396000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27451000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1461000	usd
	cdlx	Adjustments To Additional Paid In Capital Termination Of Capped Calls AdjustmentsToAdditionalPaidInCapitalTerminationOfCappedCalls	115000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3965000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-173715000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	69697000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	210033000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9297000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4451000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-145182000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	69697000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	211605000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	54000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31561000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15171000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1104000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-294000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-33866000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	225335000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	236112000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	44000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10884000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2261000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-23966000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	225335000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-173715000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-33866000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3980000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1153000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19749000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19765000	usd
	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	1235000	usd
	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	1234000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1627000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2807000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13017000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	31694000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	29956000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	131595000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	110000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-15044000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4136000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	613000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-12909000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10991000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	229000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1114000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	820000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-265000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3192000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10282000	usd
	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-18330000	usd
	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-4994000	usd
	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-2903000	usd
	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-5075000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11803000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3119000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1439000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	393000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	13423000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	8302000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-202000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14660000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8695000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	172500000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	30000000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	14167000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	50050000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	199291000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	21000	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	115000	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	48634000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	55000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	309000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5836000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1646000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20074000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-25000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-24842000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-31845000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	91830000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121985000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66988000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90140000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66988000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90067000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	73000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2453000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2958000	usd
	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	20000	usd
	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	203000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	cdlx	Noncash Or Part Noncash Acquisition Accrued Consideration NoncashOrPartNoncashAcquisitionAccruedConsideration	27451000	usd
	cdlx	Noncash Or Part Noncash Acquisition Accrued Consideration NoncashOrPartNoncashAcquisitionAccruedConsideration	0	usd
CY2024Q3	cdlx	Escrow Payments Received EscrowPaymentsReceived	200000	usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-100000	usd
CY2021Q2	cdlx	Contingent Consideration Number Of Earnout Payments ContingentConsiderationNumberOfEarnoutPayments	2	payment
CY2023Q4	cdlx	First Anniversary Annualized Recurring Revenue Cash Paid FirstAnniversaryAnnualizedRecurringRevenueCashPaid	50100000	usd
CY2023Q4	cdlx	Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered	2740418	shares
CY2024Q1	cdlx	Settlement Agreement Annualized Recurring Revenue Cash Paid SettlementAgreementAnnualizedRecurringRevenueCashPaid	25000000	usd
CY2024Q1	cdlx	Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered	3600000	shares
CY2024Q1	cdlx	Settlement Agreement Annualized Recurring Revenue Cash Paid SettlementAgreementAnnualizedRecurringRevenueCashPaid	20000000	usd
CY2024Q1	cdlx	Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered	3600000	shares
CY2024Q1	cdlx	Business Acquisition Number Of Tranches BusinessAcquisitionNumberOfTranches	2	tranche
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements. Significant items subject to such estimates and assumptions include revenue recognition, internal-use software development costs, stock-based compensation, allowance for doubtful accounts, valuation of acquired intangible assets of Bridg, valuation of contingent consideration for Bridg, valuation of long-lived assets, goodwill valuation, income tax including valuation allowance and contingencies. We base our estimates on historical experience and on assumptions that we believe are reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods and it is possible that actual results could differ from our current or revised future estimates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Macroeconomic Considerations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unfavorable conditions in the economy both in the United States and abroad may negatively affect the growth of our business and our results of operations. For example, macroeconomic events, including the changes in inflation, the U.S. Federal Reserve raising interest rates, disruptions in access to bank deposits or lending commitments due to bank failures, the Russia-Ukraine war and the Middle East conflict have led to economic uncertainty globally. Historically, during periods of economic uncertainty and downturns, businesses may slow spending on advertising, which may impact our business and our customers’ businesses.</span></div>The effect of macroeconomic conditions may not be fully reflected in our results of operations until future periods. If, however, economic uncertainty increases or the global economy worsens, our business, financial condition and results of operations may be harmed. For further discussion of the potential impacts of macroeconomic events on our business, financial condition and operating results, see the section titled "Risk Factors.
CY2024Q3	cdlx	Escrow Payments Received EscrowPaymentsReceived	200000	usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-100000	usd
CY2024Q3	us-gaap	Goodwill Gross GoodwillGross	277202000	usd
CY2024Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	117773000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	159429000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	85551000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	58977000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	13748000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12826000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	92300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	52424000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	34929000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2800000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3400000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8400000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10300000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1453000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5813000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4370000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1190000	usd
CY2024Q3	cdlx	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	0	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12826000	usd
CY2024Q3	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	44900000	usd
CY2023Q3	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	37600000	usd
	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	123300000	usd
	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	101400000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	61110000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	73064000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	187345000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	202820000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	116000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	41000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2063000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2271000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2100000	usd
CY2024Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	37900000	usd
CY2024Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	17600000	usd
CY2024Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6933000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7310000	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	22000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	14000	usd
CY2024Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6955000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	7324000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2361000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2127000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6323000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6391000	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	10000	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	17000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2024Q3	cdlx	Lease Liability LeaseLiability	8708000	usd
CY2023Q4	cdlx	Lease Liability LeaseLiability	8528000	usd
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	30000000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	213237000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	257504000	usd
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	3700000	usd
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	700000	usd
CY2020Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	usd
CY2020Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	10000	numberofdays
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.98
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	11.7457
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	85140
CY2020Q3	cdlx	Debt Instrument Convertible Redemption Period Days Before Maturity Date DebtInstrumentConvertibleRedemptionPeriodDaysBeforeMaturityDate	P36D
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2024Q3	cdlx	Debt Instrument Convertible Threshold Principal Outstanding Amount For Partial Redemption DebtInstrumentConvertibleThresholdPrincipalOutstandingAmountForPartialRedemption	75000000.0	usd
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2020Q3	us-gaap	Option Indexed To Issuers Equity Strike Price1 OptionIndexedToIssuersEquityStrikePrice1	85.14
CY2020Q3	cdlx	Option Indexed To Issuers Equity Cap Price OptionIndexedToIssuersEquityCapPrice	128.51
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	100000	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	100000	usd
CY2024Q3	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	60000000.0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	961558	shares
CY2024Q3	cdlx	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Annual Percentage Increase ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedAnnualPercentageIncrease	0.05
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1986417	shares
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	3700000	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1600000	usd
	us-gaap	Increase Decrease In Due To Affiliates Current IncreaseDecreaseInDueToAffiliatesCurrent	-45114000	usd
	us-gaap	Increase Decrease In Due To Affiliates Current IncreaseDecreaseInDueToAffiliatesCurrent	-61808000	usd
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	5817000	usd
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-15045000	usd
CY2024Q3	us-gaap	Accelerated Share Repurchases Settlement Payment Or Receipt AcceleratedShareRepurchasesSettlementPaymentOrReceipt	-4263000	usd
CY2023Q3	us-gaap	Accelerated Share Repurchases Settlement Payment Or Receipt AcceleratedShareRepurchasesSettlementPaymentOrReceipt	0	usd
CY2024Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2023Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	27268000	usd
CY2023Q4	cdlx	First Anniversary Annualized Recurring Revenue Cash Paid FirstAnniversaryAnnualizedRecurringRevenueCashPaid	50100000	usd
CY2023Q4	cdlx	Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered	2740418	shares
CY2024Q1	cdlx	Settlement Agreement Annualized Recurring Revenue Cash Paid SettlementAgreementAnnualizedRecurringRevenueCashPaid	25000000	usd
CY2024Q1	cdlx	Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered	3600000	shares
CY2024Q1	cdlx	Settlement Agreement Annualized Recurring Revenue Cash Paid SettlementAgreementAnnualizedRecurringRevenueCashPaid	20000000	usd
CY2024Q1	cdlx	Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered	3600000	shares
CY2024Q2	us-gaap	Significant Supply Commitment Remaining Minimum Amount Committed SignificantSupplyCommitmentRemainingMinimumAmountCommitted	4500000	usd
	us-gaap	Payments To Suppliers PaymentsToSuppliers	4500000	usd
CY2024Q3	us-gaap	Significant Supply Commitment Remaining Minimum Amount Committed SignificantSupplyCommitmentRemainingMinimumAmountCommitted	0	usd
CY2023Q3	us-gaap	Significant Supply Commitment Remaining Minimum Amount Committed SignificantSupplyCommitmentRemainingMinimumAmountCommitted	1300000	usd
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	13500000	usd
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	17000000.0	usd
CY2020Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	usd
CY2020Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2023Q2	cdlx	First Anniversary Annualized Recurring Revenue FirstAnniversaryAnnualizedRecurringRevenue	23200000	usd
CY2024Q1	cdlx	First Anniversary Annualized Recurring Revenue Cash Paid FirstAnniversaryAnnualizedRecurringRevenueCashPaid	25000000	usd
CY2024Q1	cdlx	Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered	3600000	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2024Q3	us-gaap	Revenues Revenues	67057000	usd
CY2023Q3	us-gaap	Revenues Revenues	79005000	usd
	us-gaap	Revenues Revenues	204301000	usd
	us-gaap	Revenues Revenues	220037000	usd
CY2024Q3	cdlx	Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts	30675000	usd
CY2023Q3	cdlx	Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts	36144000	usd
	cdlx	Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts	94476000	usd
	cdlx	Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts	108698000	usd
CY2024Q3	cdlx	Adjusted Contribution AdjustedContribution	36382000	usd
CY2023Q3	cdlx	Adjusted Contribution AdjustedContribution	42861000	usd
	cdlx	Adjusted Contribution AdjustedContribution	109825000	usd
	cdlx	Adjusted Contribution AdjustedContribution	111339000	usd
CY2024Q3	cdlx	Delivery Costs DeliveryCosts	7830000	usd
CY2023Q3	cdlx	Delivery Costs DeliveryCosts	7012000	usd
	cdlx	Delivery Costs DeliveryCosts	21664000	usd
	cdlx	Delivery Costs DeliveryCosts	20451000	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13163000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14161000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	41306000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	43314000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13194000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12430000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39712000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	38841000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12076000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15561000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42712000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44907000	usd
CY2024Q3	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	0	usd
CY2023Q3	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	78000	usd
	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	162000	usd
	cdlx	Acquisition And Integration Costs Benefit AcquisitionAndIntegrationCostsBenefit	-8146000	usd
CY2024Q3	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	100000	usd
CY2023Q3	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	8281000	usd
	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	110000	usd
	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-15045000	usd
CY2024Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	131595000	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	131595000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6970000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5990000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19749000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19765000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3364000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3314000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13470000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1118000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-145182000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23966000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-173715000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33866000	usd
CY2024Q3	us-gaap	Revenues Revenues	67057000	usd
CY2023Q3	us-gaap	Revenues Revenues	79005000	usd
	us-gaap	Revenues Revenues	204301000	usd
	us-gaap	Revenues Revenues	220037000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2847000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3323000	usd

Files In Submission

Name	View Source	Status
cdlx-20240930_cal.xml	Edgar Link	unprocessable
0001666071-24-000167-index-headers.html	Edgar Link	pending
0001666071-24-000167-index.html	Edgar Link	pending
0001666071-24-000167.txt	Edgar Link	pending
0001666071-24-000167-xbrl.zip	Edgar Link	pending
cdlx-20240930.htm	Edgar Link	pending
cdlx-20240930.xsd	Edgar Link	pending
cdlx-20240930_g1.jpg	Edgar Link	pending
cdlx_form10-qx2024q3xex101.htm	Edgar Link	pending
cdlx_form10-qx2024q3xex102.htm	Edgar Link	pending
cdlx_form10-qx2024q3xex103.htm	Edgar Link	pending
cdlx_form10-qx2024q3xex311.htm	Edgar Link	pending
cdlx_form10-qx2024q3xex312.htm	Edgar Link	pending
cdlx_form10-qx2024q3xex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_2.jpg	Edgar Link	pending
image_3.jpg	Edgar Link	pending
image_4.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
cdlx-20240930_def.xml	Edgar Link	unprocessable
cdlx-20240930_lab.xml	Edgar Link	unprocessable
cdlx-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cdlx-20240930_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDLX
Cardlytics, Inc. Stock $cdlx

2024 Q4 Form 10-Q Financial Statement

#000166607124000167 Filed on November 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX Cardlytics, Inc. Stock $cdlx

2024 Q4 Form 10-Q Financial Statement

#000166607124000167 Filed on November 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX
Cardlytics, Inc. Stock $cdlx